Inactive Instrument

Annidis Corporation

RHA.H

CA03589A1003

Advanced Medical Equipment & Technology

Annidis Corporation announced that it has received CAD 0.1 million in funding from YIMAI Technology International Company Limited

April 14, 2016

On April 14, 2016, Annidis Corporation closed the transaction.

Latest news about Annidis Corporation

Annidis Corporation Announces Executive Resignations	26/18/26	CI
Annidis Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017	24/17/24	CI
Annidis Corporation Announces Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2017	26/17/26	CI
Annidis Corporation Announces Audited Consolidated Earnings Results for the First Quarter Ended March 31, 2017	26/17/26	CI
Annidis Corporation Announces Audited Consolidated Earnings Results for the Twelve Months Ended December 31, 2016	29/17/29	CI
Annidis Corporation Announces Executive Changes	24/17/24	CI
Annidis Corporation announced that it expects to receive CAD 2.18 million in funding	30/16/30	CI
Annidis Corporation Announces Private Placement of $500,000 Promissory Note	21/16/21	CI
Annidis Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter Ended June 30, 2016	08/16/08	CI
Annidis Corporation Announces the Resignation of Michael Mueller as Board of Director	08/16/08	CI
Annidis Corporation announced that it has received CAD 0.5 million in funding from Mistarunited Technology Co., Limited	01/16/01	CI
Annidis Corporation Announces Private Placement of $221,000 Promissory Note	09/16/09	CI
Annidis Corporation announced that it has received CAD 0.22 million in funding from Mistarunited Technology Co., Limited	29/16/29	CI
Annidis Corporation Auditor Raises 'Going Concern' Doubt	29/16/29	CI
Annidis Corporation Announces Management Changes	19/16/19	CI
Annidis Corporation announced that it has received CAD 1.3 million in funding from YIMAI Technology International Company Limited	18/16/18	CI
Annidis Corporation announced that it has received CAD 0.1 million in funding from YIMAI Technology International Company Limited	14/16/14	CI
Annidis Corporation announced that it expects to receive CAD 0.1 million in funding from YIMAI Technology International Company Limited	31/16/31	CI
Annidis Corporation announced that it has received CAD 0.15 million in funding from YIMAI Technology International Company Limited	17/16/17	CI
Annidis Corporation announced that it has received CAD 0.87 million in funding from YIMAI Technology International Company Limited	04/16/04	CI
Annidis Corporation Announces Private Placement of $150,000 Promissory Note	23/16/23	CI
Annidis Corporation Announces Management Changes	06/16/06	CI
Annidis Corporation Announces Earnings Results for the Nine Months Ended September 30, 2015	21/15/21	CI
Annidis Corporation announced that it expects to receive funding from YIMAI Technology International Company Limited.	11/15/11	CI
Annidis Corporation announced that it has received CAD 0.15 million in funding from YIMAI Technology International Company Limited	25/15/25	CI

Annidis Corporation develops and markets imaging technologies to eye care professionals. The Company has developed a multi-spectral imaging (MSI) system for retinal and choroidal assessment (the RHA). The RHA provides eye-care professionals with a screening tool for early detection and diagnosis of a range of pathologies. The RHA is an ocular pathology management system that integrates MSI with analytic software and management of ocular pathologies, such as glaucoma, age-related macular degeneration and diabetic retinopathy. Its RHA collects and combines multi-spectral information. The RHA is a non-invasive instrument that uses MSI to take pictures of the retinal layers of eye. The images are then processed using the RHA Report software to reveal various layers in the back of the eye. The Company is also engaged in developing RHA Platinum, which is under development with beta units in clinical testing that allows doctors to visualize choroidal and retinal vasculature non-invasively.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+12.15%	23TCr
DANAHER CORPORATION	+14.90%	20TCr
INTUITIVE SURGICAL, INC.	+18.22%	14TCr
BOSTON SCIENTIFIC CORPORATION	+29.15%	11TCr
SIEMENS HEALTHINEERS AG	+0.53%	6.41TCr
EDWARDS LIFESCIENCES CORPORATION	+16.92%	5.37TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.33%	5.17TCr
AGILENT TECHNOLOGIES, INC.	+10.93%	4.52TCr
GE HEALTHCARE TECHNOLOGIES INC.	+5.87%	3.74TCr

Other Advanced Medical Equipment & Technology